Preticks
.
Follow Us
TR
News Details
Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog
About Chiasma, Inc.
NASDAQ: $CHMA
Notified: $6.46
13:28 EDT
Price Chart